Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
Likely Determinants of Successful TKI Treatment Stoppage Identified in CML
January 16th 2021Tyrosine kinase inhibitor (TKI) therapy enables patients with chronic myeloid leukemia (CML) to reach life expectancies equivalent to the general population and treatment-free remission, but quality of life can deteriorate with treatment.
Read More
Givosiran Use Linked to Improvement in Porphyria Attacks
January 13th 2021Use of the RNA inhibitor givosiran was shown to reduce expression of delta-aminolevulinic acid synthase 1, in turn reducing the severity of acute attacks and chronic symptoms for patients with severe hepatic porphyria.
Read More
Jardiance 1 Step Closer to FDA Approval for Use in Heart Failure
January 11th 2021The FDA today accepted Boehringer Ingelheim and Eli Lilly’s supplemental New Drug Application for Jardiance (empagliflozin), the sodium glucose co-transporter 2 inhibitor being investigated for use in patients with heart failure.
Read More
Possible New Association Found Between MRD and PFS, OS Among Patients With Mantle Cell Lymphoma
January 7th 2021A recent meta-analysis appearing in Journal of Cancer indicates a connection between minimal residual disease (MRD)–positive status and worse progression-free survival (PFS) and overall survival (OS) following induction and consolidation therapies.
Read More
Risk Factors for Increased Mortality Among Patients With MM, COVID-19 Identified
January 7th 2021Age, renal disease, and suboptimal myeloma control were among the many factors identified in a recent study as increasing the risk of death from coronavirus disease 2019 (COVID-19) for patients being treated for multiple myeloma (MM).
Read More
An abstract from last month’s San Antonio Breast Cancer Symposium identifies factors linked with longer-term controlled substance use after treatment of breast cancer with mastectomy plus breast reconstruction in women receiving opioids, benzodiazepines, and other sedative/hypnotics.
Read More
Self-Care Intervention Fails to Significantly Improve Outcomes Among Patients With Heart Failure
December 21st 2020Hoping to improve outcomes among patients with acute heart failure discharged from the emergency department, study findings show that 30-day improvements from a self-care intervention were not sustainable through 90 days.
Read More
Top 5 Most-Read HIV Articles of 2020
December 21st 2020Four of our top 5 HIV articles for 2020 saw the HIV pandemic overlap with the coronavirus disease 2019 pandemic and had Anthony Fauci, MD, in common. The fifth is from this year's AIDS 2020 virtual conference, itself a product of the overlapping pandemics.
Read More
Uptick in Early-Stage Breast Cancer Diagnoses Seen Among Minority Women Following ACA Implementation
December 14th 2020Compared with before the Affordable Care Act (ACA), study results show there was an increase in diagnoses of early-stage breast cancer among younger vs older minority women after the act.
Read More
GI Disorders Linked to Higher Costs, Hospitalizations Among Patients Living With HIV
December 10th 2020Results from a 5-year study show significantly higher rates of several gastrointestinal (GI) disorders, as well as hospital-related costs, among patients living with HIV compared with controls.
Read More